Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07517666) titled 'Genetic Information for Families After Tumor Testing Study' on April 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
Primary Sponsor: Abramson Cancer Center at Penn Medicine
Condition:
Cancer
Intervention:
Other: Interactive Chatbot
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: April 2026
Target Sample Size: 100
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07517666
Published by HT Digital Content Serv...